Twist Bioscience Corporation (TWST)

Import this data to Google Sheets with:

=jivedata("TWST","financials")

Full statements spill as a table. For one cell: =jivedata("TWST","Revenue") or =jivedata("TWST","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Twist Bioscience Corporation

TWST • CIK 0001581280

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Including Assessed Tax	$245,109	$312,974	$376,572	$431,798
Operating Income (Loss)	$-217,159	$-220,831	$-136,259	$-144,977
Gain (Loss) on Disposition of Business	—	—	$48,847	$0
Investment Income, Interest	$14,365	$15,344	$11,364	$8,018
Other Nonoperating Income (Expense)	$-667	$-2,650	$-903	$1,106
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest	$-203,466	$-208,166	$-76,951	$-135,853
Income Tax Expense (Benefit)	$1,152	$560	$719	$864
Net Income (Loss) Attributable to Parent	$-204,618	$-208,726	$-77,670	$-136,717
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	$-203,531	$-208,492	$-77,775	$-136,508
Weighted Average Number of Shares Outstanding, Basic	56,885,000	58,016,000	59,808,000	61,934,000
Cost of Revenue	$155,380	$179,625	$185,570	$207,413
Research and Development Expense	$106,894	$90,852	$80,285	$71,864
Selling, General and Administrative Expense	$189,738	$218,398	$246,976	$290,293
Restructuring Costs	$16,169	$0	$0	$0
Asset Impairment Charges	—	$44,930	$0	$0
Costs and Expenses	$462,268	$533,805	$512,831	$576,775
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax	$1,510	$203	$-50	$-36
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax	$-423	$31	$-55	$245
Sublease Income	—	—	$1,068	$2,757

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$286,470	$226,316	$183,049	$117,436
Short-term Investments	$49,943	$50,083	$49,385	$49,403
Property, Plant and Equipment, Net	$131,830	$102,520	$102,283	$111,888
Accounts Receivable, after Allowance for Credit Loss, Current	$44,064	$34,903	$57,019	$65,055
Operating Lease, Right-of-Use Asset	$71,531	$58,829	$49,377	$68,736
Inventory, Net	$32,063	$24,078	$28,309	$35,162
EquitySecuritiesFVNINoncurrent	—	—	$54,337	$68,087
Prepaid Expense and Other Assets, Current	$11,716	$11,396	$15,204	$54,239
Goodwill	$85,811	$85,811	$82,195	$82,195
Assets, Current	$424,256	$346,776	$332,966	$321,295
Finite-Lived Intangible Assets, Net	$54,483	$14,478	$13,425	$12,730
Restricted Cash, Noncurrent	$2,811	$2,816	$2,376	$2,130
Other Assets, Noncurrent	$5,681	$3,093	$4,902	$5,376
Assets	$776,403	$614,323	$641,861	$672,437
Operating Lease, Liability, Noncurrent	$79,173	$70,221	$61,750	$84,960
Other Long-term Debt	—	—	$15,000	$15,000
Other Liabilities, Noncurrent	$475	$407	$747	$6,483
Liabilities	$152,971	$141,634	$168,903	$226,698
Accounts Payable, Current	$14,052	$1,630	$11,094	$17,043
Accrued Liabilities, Current	$10,754	$15,104	$23,053	$20,450
Employee-related Liabilities, Current	$25,818	$33,650	$31,288	$34,879
Operating Lease, Liability, Current	$14,896	$14,805	$13,822	$8,630
Other Liabilities, Current	$7,803	$5,817	$12,149	$59,703
Liabilities, Current	$73,323	$71,006	$91,406	$120,255
Common Stock, Value, Issued	$0	$0	$0	$1
Additional Paid in Capital	$1,657,222	$1,715,119	$1,793,163	$1,875,550
Accumulated Other Comprehensive Income (Loss), Net of Tax	$-756	$-522	$-627	$-655
Retained Earnings (Accumulated Deficit)	$-1,033,034	$-1,241,908	$-1,319,578	$-1,429,157
Stockholders' Equity Attributable to Parent	$623,432	$472,689	$472,958	$445,739
Common Stock, Shares Authorized	100,000,000	100,000,000	200,000,000	200,000,000
Common Stock, Shares, Issued	57,557,000	58,877,000	60,631,000	62,674,000
Accounts Receivable, Allowance for Credit Loss	$200	$700	$600	$600
Depreciation	—	$27,300	$23,800	$18,600
Asset Impairment Charges	—	$44,930	$0	$0
Capitalized Computer Software, Net	$7,900	$5,200	$3,200	$3,200
Capitalized Computer Software, Amortization	—	$2,600	$2,900	$2,900
Inventory, Raw Materials, Gross	$27,024	$17,316	$20,191	$25,549
Inventory, Work in Process, Gross	$1,113	$2,146	$2,265	$2,943
Inventory, Finished Goods, Gross	$3,926	$4,616	$5,853	$5,023
Property, Plant and Equipment, Gross	$182,486	$178,163	$197,277	$223,596
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment	$50,656	$75,643	$94,994	$111,708
Taxes Payable, Current	$4,374	$2,725	$4,543	$7,376
Deferred Revenue, Current	$2,999	$2,131	$6,884	$6,466

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$-204,618	$-208,726	$-77,670	$-136,717
Net Cash Provided by (Used in) Operating Activities	$-142,474	$-64,094	$-47,628	$-53,072
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$-27	$126	$143	$176
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-90,978	$-60,149	$-43,707	$-84,339
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$289,281	$229,132	$185,425	$112,351
Depreciation, Depletion and Amortization	$29,310	$31,432	$24,853	$25,390
Payments to Acquire Property, Plant, and Equipment	$27,779	$5,076	$28,004	$40,051
Gain (Loss) on Disposition of Property Plant Equipment	$-6,785	$-44,930	$0	$0
Payments to Acquire Investments	$76,345	$51,905	$49,393	$59,598
Operating Lease, Impairment Loss	$2,573	$940	$-20	$-20
Proceeds from Sale, Maturity and Collection of Investments	$154,736	$53,910	$50,135	$59,510
Share-based Payment Arrangement, Noncash Expense	$30,278	$50,925	$64,459	$66,468
Proceeds from Divestiture of Businesses	—	—	$2,500	$0
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	—	—	$0	$0
Net Cash Provided by (Used in) Investing Activities	$50,612	$-3,071	$-24,762	$-45,240
Gain (Loss) on Disposition of Business	—	—	$48,847	$0
Other Noncash Income (Expense)	—	—	$-2,203	$433
Increase (Decrease) in Accounts Receivable	$4,320	$-8,444	$22,382	$15,707
Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised	$1,379	$7,100	$9,343	$9,674
Increase (Decrease) in Inventories	$-7,238	$-7,986	$4,229	$9,220
Proceeds from Issuance of Other Long-term Debt	—	—	$15,000	$0
Increase (Decrease) in Prepaid Expense and Other Assets	$4,166	$-382	$3,717	$20,855
Increase (Decrease) in Other Noncurrent Assets	$-1,376	$-431	$1,568	$1,267
Increase (Decrease) in Accounts Payable	$-2,508	$-11,805	$9,332	$4,296
Net Cash Provided by (Used in) Financing Activities	$911	$6,890	$28,540	$13,797
Increase (Decrease) in Accrued Liabilities	$2,578	$4,415	$5,751	$4,123
Increase (Decrease) in Employee Related Liabilities	$-1,099	$7,875	$-2,405	$5,888
Increase (Decrease) in Other Operating Liabilities	$-108	$-2,317	$6,612	$8,529
Income Taxes Paid, Net	$420	$344	$683	$1,189
Capital Expenditures Incurred but Not yet Paid	—	$92	$2,408	$3,929
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$6,676	$0	$0	$24,773
Stock Issued	$5,860	$0	$0	$10,000
Debt Conversion, Converted Instrument, Amount	$3,711	$0	$0	$0

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("TWST","financials")

Full statements spill as a table. For one cell: =jivedata("TWST","Revenue") or =jivedata("TWST","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.